SynthesisDiabetic medicine : a journal of the British Diabetic Association2013

Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.

N Freemantle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.